- PROFESSOR Surgery
Am Board of Surgery (Sub: General Vascular Surg)
American Board of Surgery
MD, Albany Medical College
Peter Bent Brigham Hospital
- Dr John Lantis is the Vice Chairman of the Department of Surgery at Mount Sinai St. Luke’s-and Roosevelt Hospitals in New York City, where he is also the Chief of Vascular and Endovascular Surgery, and the Director of Surgical Clinical Research. He holds the academic title of Professor of Surgery at the Icahn School of Medicine at Mount Sinai.
Dr Lantis’ clinical practice spans the fields of Vascular/Endovascular Surgery, and lower extremity wound healing. He directs a clinical/basic science research program in the field of lower extremity wound healing and tissue repair and is published extensively. He is a founding member of the American Board of Wound Medicine and Surgery. He currently sits on the editorial board of WOUNDS, and is a reviewer for half a dozen other journals. To date he is/or has been the principal investigator on more than 55 multi center and single center chronic wound and vascular surgery trials.
Alcantara S, Yang CK, Sasson J, Goss S, Benvenisty A, Todd G, Lantis J. The evidence for nonoperative management of visceral artery dissections: a single-center experience. Annals of vascular surgery 2015 Jan; 29(1).
Lantis JC, Boone D, Lee L, Mendes D, Benvenisty A, Todd G. The effect of percutaneous intervention on wound healing in patients with mixed arterial venous disease. Annals of vascular surgery 2011 Jan; 25(1).
Alcantara SD, Wuamett JC, Lantis JC, Ulkatan S, Bamberger P, Mendes D, Benvenisty A, Todd G. Outcomes of combined somatosensory evoked potential, motor evoked potential, and electroencephalography monitoring during carotid endarterectomy. Annals of vascular surgery 2014 Apr; 28(3).
Kim PJ, Attinger CE, Steinberg JS, Evans KK, Lehner B, Willy C, Lavery L, Wolvos T, Orgill D, Ennis W, Lantis J, Gabriel A, Schultz G. Negative-pressure wound therapy with instillation: international consensus guidelines. Plastic and reconstructive surgery 2013 Dec; 132(6).
Lantis JC, Marston WA, Farber A, Kirsner RS, Zhang Y, Lee TD, Cargill DI, Slade HB. The influence of patient and wound variables on healing of venous leg ulcers in a randomized controlled trial of growth-arrested allogeneic keratinocytes and fibroblasts. Journal of vascular surgery 2013 Aug; 58(2).
Schwartz JA, Lantis JC, Gendics C, Fuller AM, Payne W, Ochs D. A prospective, non comparative, multicenter study to investigate the effect of cadexomer iodine on bioburden load and other wound characteristics in diabetic foot ulcers. International wound journal 2013 Apr; 10(2).
Manizate F, Fuller A, Gendics C, Lantis JC. A prospective, single-center, nonblinded, comparative, postmarket clinical evaluation of a bovine-derived collagen with ionic silver dressing versus a carboxymethylcellulose and ionic silver dressing for the reduction of bioburden in variable-etiology, bilateral lower-extremity wounds. Advances in skin & wound care 2012 May; 25(5).
Li RX, Luo J, Balaram SK, Chaudhry FA, Lantis JC, Shahmirzadi D, Konofagou EE. In-vivo Pulse Wave Imaging for arterial stiffness measurement under normal and pathological conditions. Conference proceedings : ... Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual Conference 2011; 2011.
Snyder RJ, Driver V, Fife CE, Lantis J, Peirce B, Serena T, Weir D. Using a diagnostic tool to identify elevated protease activity levels in chronic and stalled wounds: a consensus panel discussion. Ostomy/wound management 2011 Dec; 57(12).
Dake MD, Ansel GM, Jaff MR, Ohki T, Saxon RR, Smouse HB, Zeller T, Roubin GS, Burket MW, Khatib Y, Snyder SA, Ragheb AO, White JK, Machan LS. Paclitaxel-eluting stents show superiority to balloon angioplasty and bare metal stents in femoropopliteal disease: twelve-month Zilver PTX randomized study results. Circulation. Cardiovascular interventions 2011 Oct; 4(5).
Goudie EB, Gendics C, Lantis JC. Multimodal therapy as an algorithm to limb salvage in diabetic patients with large heel ulcers. International wound journal 2012 Apr; 9(2).
Lugo JZ, Deitch JS, Yu A, Jang JH, Patel R, Slova D, Lantis J, Leitman IM. Demographic and laboratory data may predict positive temporal artery biopsy. The Journal of surgical research 2011 Oct; 170(2).
Raad W, Lantis JC, Tyrie L, Gendics C, Todd G. Vacuum-assisted closure instill as a method of sterilizing massive venous stasis wounds prior to split thickness skin graft placement. International wound journal 2010 Apr; 7(2).
Schwartz J, Goss S, Facchin F, Manizate F, Gendics C, Braitman E, Lantis J. A prospective two-armed trial assessing the efficacy and performance of a silver dressing used postoperatively on high-risk, clean surgical wounds. Ostomy/wound management 2014 Apr; 60(4).
Lantis JC, Boone D, Gendics C, Todd G. Analysis of patient cost for recombinant human platelet-derived growth factor therapy as the first-line treatment of the insured patient with a diabetic foot ulcer. Advances in skin & wound care 2009 Apr; 22(4).
Blume PA, Walters J, Payne W, Ayala J, Lantis J. Comparison of negative pressure wound therapy using vacuum-assisted closure with advanced moist wound therapy in the treatment of diabetic foot ulcers: a multicenter randomized controlled trial. Diabetes care 2008 Apr; 31(4).
Clair DG, Dayal R, Faries PL, Bernheim J, Nowygrod R, Lantis JC, Beavers FP, Kent KC. Tibial angioplasty as an alternative strategy in patients with limb-threatening ischemia. Annals of vascular surgery 2005 Jan; 19(1).
Joseph KA, Ditkoff BA, Komenaka I, Mercado CL, Millman SL, Lantis J, El-Tamer M, Horowitz E, Schnabel F. Acquired arteriovenous fistula of the breast. The breast journal; 10(2).
Yang CK, Alcantara S, Goss S, Lantis JC. Cost analysis of negative-pressure wound therapy with instillation for wound bed preparation preceding split-thickness skin grafts for massive (>100 cm(2)) chronic venous leg ulcers. Journal of vascular surgery 2015 Apr; 61(4).
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Below are financial relationships with industry reported by Dr. Lantis during 2014 and/or 2015. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
- Kinetic Concepts Inc.(KCI); Smith and Nephew
Scientific Advisory Board:
- Kinetic Concepts Inc.(KCI); MacroCure Ltd.; Smith and Nephew
Industry-Sponsored Lectures: MSSM faculty occasionally give lectures at events sponsored by industry, but only if the events are free of any marketing purpose.
- Kinetic Concepts Inc.(KCI); Smith and Nephew
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.
1090 Amsterdam Ave, Suite 7A
New York, NY 10025